PPT-Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin

Author : iris | Published Date : 2022-02-10

Blockers Impact on Adverse Outcomes in Hospitalized Patients with Severe Acute Respiratory Distress Syndrome Coronavirus 2 SARSCoV2 THE BRACE CORONA TRIAL Renato

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Continuing versus Suspending Angiotensin..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin: Transcript

Blockers Impact on Adverse Outcomes in Hospitalized Patients with Severe Acute Respiratory Distress Syndrome Coronavirus 2 SARSCoV2 THE BRACE CORONA TRIAL Renato D Lopes MD PhD on behalf of the BRACE CORONA Investigators. Milton Packer, John J.V. McMurray, Akshay S. Desai, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor C. Shi, Scott D. Solomon, Karl Swedberg and Michael R. Zile for the PARADIGM-HF Investigators and Committees. Shannon Harris, DNP, FNP. Objectives. Causes of hypertension. Classifications of hypertension. Risk factors. Diagnosis . Complications. Management . Final thoughts. Hypertension. The #1 modifiable risk factor for stroke. Drugs Acting on the Renin-Angiotensin-Aldosterone System. Physiology of the renin-angiotensin-aldosterone system. Angiotensin-converting enzyme inhibitors. Angiotensin II receptor blockers. Aldosterone antagonists. Dr. . Naser. Ashraf . Department of Basic Medical Sciences . College of Medicine . Majmaah University . Objectives . List major drug groups used in treatment of heart failure . Explain mechanism of action of digitalis and its major effects . MARLON T. CO,MD. DISCLOSURE. Advisory board of Merck Philippines. Ps-DZ, 2009. Global Leading Risks for Death, 2010. Systolic blood pressure > 115 mmHg. Global Burden of Disease Study 2010 , . Lancet . IN. TYPE I DIABETIC NEPHROPATHY. DR.NASIM MUSA. Type I –IDDM is characterized by. The abrupt onset of symptoms. Insulinopenia. Dependence on injected insulin for life. Proneness to . ketoacidosis. .. as antagonists . for AT. 2. . receptors to decrease . bradykinin. production . Tina . Stutzman. Nick Swenson. 20.109. May 12, 2010. Hypertension is related to renal and cardiac . f. ailure . Hypertension (high blood pressure). ACEIs are among the most widely prescribed antihypertensive drugs. .. In general, these . drugs are . well absorbed from the GI tract, reaching peak . serum conc. within . 1 to 4 hours. . These drugs are . Assistant lecturer Ola . N. assr. 12 Nov 2015 MSc Clinical Pharmacy . Aim and objectives. By the end of the session, the students will be able to:. Know indications, side effects, contraindications, doses and drug interactions of all drugs mentioned in the list.. System. The Cardiovascular Continuum . Myocardial Infarction. Heart Failure. End-Stage Heart Disease. Plaque Rupture. Risk Factors. Hypertension. Hyperlipidemia. Diabetes. Atherosclerosis. Endothelial Dysfunction. enzyme inhibitors (ACE inhibitors). inhibit the conversion of angiotensin I to angiotensin II.. The. . main . indications of ACE inhibitors are shown below.. Heart Failure. ACE inhibitors are used in all grades of heart failure, . W. Hinton. 1,2. , H. Dambha-Miller. 3. , M.Feher. 1. , J. Sheppard. 1. , M.Joy. 1. , N. Munro. 2,4. , . S. de Lusignan. 1,5. 1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. BP. Congest-ion*. Haemo. -globin. K. +. GFR. BNP#. Echo. Diuretics. . . . . . . . ACEi/ARB. . . . I. ARNI. . . . I. I. β. -Blocker. R?. . R?. . I. MRA. . Converting. . Enzyme. . Inhibitors. . or . Angiotensin. . Receptor. . Blockers. . Use and. . Covid-. 19. . Infection . Among. . Patients with. . Hypertension. Jaejin. . An. ,. . Rong. . Wei,.

Download Document

Here is the link to download the presentation.
"Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.